Related Experiment Video
Updated: Mar 9, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
CD68-Positive Cells in Hepatic Angiomyolipoma
Hitoshi Tochio1, Eriko Tamaki, Yukihiro Imai
1Department of Clinical Laboratory Medicine, Kobe City Medical Center General Hospital, Kobe, , Japan.
Sonazoid contrast agent uptake in hepatic angiomyolipoma is linked to macrophage density. Immunohistochemical analysis confirmed CD68-positive cells correlate with Sonazoid enhancement in ultrasonography.
Area of Science:
- Hepatobiliary imaging
- Tumor pathology
- Radiology
Background:
- Hepatic angiomyolipoma is a benign liver tumor.
- Sonazoid is a contrast agent used in ultrasonography.
- Understanding contrast agent behavior in tumors is crucial for diagnosis.
Purpose of the Study:
- To investigate the relationship between Sonazoid uptake and macrophage presence in hepatic angiomyolipoma.
- To determine if macrophage density correlates with Sonazoid enhancement in the postvascular phase.
Main Methods:
- Analysis of four resected hepatic angiomyolipoma specimens.
- Sonazoid-enhanced ultrasonography to assess contrast uptake.
- Immunohistochemical staining for CD68 to identify macrophages.
Main Results:
- Sonazoid uptake was observed in the postvascular phase in all cases.
- CD68-positive cells (macrophages) were present in all tumors.
- Tumor macrophage density correlated with the degree of Sonazoid uptake.
Conclusions:
- Macrophage density is a key factor in Sonazoid uptake in hepatic angiomyolipoma.
- Sonazoid-enhanced ultrasonography may provide insights into tumor composition.
- Further research can explore the diagnostic potential of this finding.
More Related Videos
08:07Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells
Published on: January 7, 2019
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019